Big Pharma Split Corp. (PRM)
TSX
16.00
+0.99 (+6.60%)
Closed
Aug 24, 2026
Day's Range
15.4816.10
52 wk Range
11.5816.10
Financial Statements - PRM - Big Pharma Split Corp.
Revenue
5.55M▲ 1175.3%
Net Income
5.02M▲ 37412.4%Net Margin 90.5%
Free Cash Flow
-890.13K▼ 152.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 5.55M | 435.58K | 306.54K | 3.71M | 5.35M | 589.25K |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 5.02M | 13.40K | -144.89K | 3.14M | 4.85M | 265.42K |
| Income Tax | - | - | - | - | - | - |
| Net Income | 5.02M | 13.40K | -144.89K | 3.14M | 4.85M | 265.42K |
| EPS Basic | - | -0.47 | -0.53 | 1.58 | 3.27 | -0.22 |
| EPS Diluted | - | -0.47 | -0.53 | 1.58 | 3.27 | -0.22 |
| Basic Shares Outstanding | - | 1.14M | 1.21M | 1.50M | 1.28M | 995.80K |
| Diluted Shares Outstanding | - | 1.14M | 1.21M | 1.50M | 1.28M | 995.80K |
| Ebit | - | - | - | - | - | - |
| Ebitda | - | - | - | - | - | - |
| Net Income Continuous Operations | 4.40M | -538.62K | -645.35K | 2.38M | 4.20M | -217.38K |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | -500 | -5.21K | - | -43.49K | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
